CurrentCardio
Get Weekly

CurrentCardio coverage · page 2 of 15

European Journal of Heart Failure

Briefs 41–80 of 588 CurrentCardio has covered from this journal, newest publication first

Latest from European Journal of Heart Failure

All coverage, newest first

  1. Eur J Heart Fail

    Catheter ablation of atrial fibrillation in patients with heart failure: a trial-level meta-analysis

    Meta-analysisArrhythmias & EP

  2. Eur J Heart Fail

    Urinary biomarker thresholds to detect diuretic resistance and insufficient diuretic response in acute heart failure

    Diagnostic or prognostic studyHeart failure

  3. Eur J Heart Fail

    Cardiac myosin-binding protein C in community-based patients with suspected heart failure

    Diagnostic or prognostic studyHeart failure

  4. Eur J Heart Fail

    First Italian multicentre registry for Mechanically Assisted Circulatory Support (ITAMACS) report: 12-year experience of over 1000 durable LVAD patients

    Cohort studyHeart failure

  5. Eur J Heart Fail

    A high proportion of children with severe cardiomyopathies show both myocarditis and genetic predispositions

    Cohort studyHeart failure

  6. Eur J Heart Fail

    Prevention of heart failure in women: an expert consensus statement on sex-specific risk factors

    Guideline or statementHeart failure

  7. Eur J Heart Fail

    Consistent efficacy of vutrisiran across sexes in transthyretin cardiac amyloidosis: evidence from the HELIOS-B trial

    Secondary analysisHeart failure

  8. Eur J Heart Fail

    Time-dependent effects of interleukin-1 blockade by anakinra in myocarditis and inflammatory cardiomyopathy

    Cohort studyHeart failure

  9. Eur J Heart Fail

    Diuretic resistance risk and the efficacy of torsemide vs furosemide: a post-hoc analysis of the TRANSFORM-HF trial

    Secondary analysisHeart failure

  10. Eur J Heart Fail

    Early effects of SGLT2 inhibitors in acute heart failure: an individual patient-level meta-analysis

    Meta-analysisHeart failure

  11. Eur J Heart Fail

    Clinical and cardiac magnetic resonance phenotype of probable viral vs probable immune-mediated acute myocarditis

    Cohort studyHeart failure

  12. Eur J Heart Fail

    Chronotropic response in heart failure: clinical, structural, and metabolic predictors and long-term mortality

    Cohort studyHeart failure

  13. Eur J Heart Fail

    Acute myocardial infarction vs acute decompensated heart failure in cardiogenic shock: a systematic review and meta-analysis of clinical phenotypes and mortality

    Meta-analysisAcute care & resuscitation

  14. Eur J Heart Fail

    Prevalence and prognostic role of untreated moderate-to-severe tricuspid regurgitation: a systematic review and meta-analysis

    Meta-analysisValvular & structural

  15. Eur J Heart Fail

    Bridging the gap: adapting heart failure guidelines for resource-limited settings: A European Journal of Heart Failure expert consensus document

    Guideline or statementHeart failure

  16. Eur J Heart Fail

    Baseline characteristics of patients with transthyretin amyloid cardiomyopathy in the CARDIO-TTRansform trial of eplontersen

    Randomised controlled trialHeart failure

  17. Eur J Heart Fail

    Cardio-obstetrics care: challenging scenarios in heart failure and future directions

    Research articleCardio-oncology & other

  18. Eur J Heart Fail

    Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: findings from ATTRibute-CM

    Secondary analysisHeart failure

  19. Eur J Heart Fail

    Event rates of patients with stable heart failure with reduced ejection fraction and newly diagnosed obstructive or central sleep apnoea

    Secondary analysisHeart failure

  20. Eur J Heart Fail

    Genetic determinants of severity and recurrence in arrhythmia-induced cardiomyopathy

    Cohort studyHeart failure

  21. Eur J Heart Fail

    Cost-effectiveness of finerenone in heart failure with mildly reduced or preserved ejection fraction: Insights from FINEARTS-HF

    Randomised controlled trialHeart failure

  22. Eur J Heart Fail

    Cardiovascular events after acute myocardial infarction complicated by low ejection fraction and/or congestion: a landmark analysis of the PARADISE-MI trial

    Secondary analysisCoronary & ACS

  23. Eur J Heart Fail

    Epicardial adipose tissue is associated with impaired outcomes in genotype-positive hypertrophic cardiomyopathy

    Cohort studyHeart failure

  24. Eur J Heart Fail

    Current state of knowledge on the epidemiology, aetiology, diagnosis, and management of heart involvement in eosinophilia. A Clinical Consensus Statement of the ESC Working Group on Myocardial & Pericardial Diseases

    Guideline or statementCardio-oncology & other

  25. Eur J Heart Fail

    Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomized clinical trial

    Randomised controlled trialHeart failure

  26. Eur J Heart Fail

    Improved outcome up to 10 years after intravenous immunoglobulin therapy in patients with dilated cardiomyopathy

    Secondary analysisHeart failure

  27. Eur J Heart Fail

    Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial

    Secondary analysisCardiometabolic & kidney

  28. Eur J Heart Fail

    Anthropometric adiposity measures and natriuretic peptides in heart failure screening: population-based evidence from the PORTHOS study

    Cross-sectional studyHeart failure

  29. Eur J Heart Fail

    Incident cancer in heart failure, myocardial infarction or both: a report from a global federated research network

    Cohort studyCardio-oncology & other

  30. Eur J Heart Fail

    Performance of prediction models for incident heart failure and heart failure hospitalization in individuals with type 2 diabetes: a systematic review and meta-analysis

    Meta-analysisCardiometabolic & kidney

  31. Eur J Heart Fail

    Prevalence and predictors of high inflammatory risk in heart failure subtypes: findings from the global POSEIDON study

    Cohort studyHeart failure

  32. Eur J Heart Fail

    Short- and long-term mortality in patients hospitalized for dyspnoea with acute heart failure, respiratory infection, or both: insights from the PARADISE cohort

    Cohort studyHeart failure

  33. Eur J Heart Fail

    Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials

    Trial designHeart failure

  34. Eur J Heart Fail

    Association of patient-centred remote monitoring with clinical outcomes in patients with prior hospitalization: the TELESAT PRIOR-HF study

    Secondary analysisHeart failure

  35. Eur J Heart Fail

    Update on heart transplantation: a consensus document

    Guideline or statementHeart failure

  36. Eur J Heart Fail

    Fragility analysis of cardiovascular outcomes with finerenone in patients with Type 2 diabetes mellitus and chronic kidney disease

    Meta-analysisCardiometabolic & kidney

  37. Eur J Heart Fail

    Organ perfusion pressure as a hemodynamic target in cardiogenic shock

    Cohort studyAcute care & resuscitation

  38. Eur J Heart Fail

    Kidney dysfunction and pulmonary vascular disease in heart failure with preserved ejection fraction

    Cohort studyHeart failure

  39. Eur J Heart Fail

    Modification of the association between age and mortality in heart failure by frailty status

    Cohort studyHeart failure

  40. Eur J Heart Fail

    Epidemiological trends in hypertrophic cardiomyopathy in adults—a Swedish nationwide registry study

    Cohort studyHeart failure

All 588 Briefs in ExploreShowing Briefs 41–80 of 588, newest first